Contingency Management for Alcohol Use Disorders

Not Applicable

Completed

• Conditions: Contingency Management; Alcohol Use Disorder
• Interventions: Behavioral: Prize Contingency Management for Alcohol Abstinence; Behavioral: Standard Care

• Registration Number: NCT02135237
• Lead Sponsor: UConn Health

Brief Summary

Contingency management (CM) treatments are highly efficacious in improving outcomes of substance abusing patients. However, CM has rarely been applied to individuals with alcohol use disorders, primarily because of technological limitations in monitoring drinking. The Secure Continuous Remote Alcohol Monitor (SCRAMx®) is a new technology designed to continuously monitor alcohol consumption 24 hours a day for 7 days per week. The purpose of this study is to evaluate the efficacy of CM in reducing alcohol use using SCRAMx. In total, 120 alcohol abusing or dependent patients initiating outpatient treatment at community-based clinics will be randomly assigned to one of two conditions: standard care, or standard care plus CM with reinforcement based on results of SCRAMx readings. Compared with standard care, it is expected that CM will result in fewer drinking days and longer durations of continuous non-drinking days.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01
• Study First Submitted: 2014-02-24
• Study First Submitted QC: 2014-05-07
• Study First Posted: 2014-05-09
• Primary Completion: 2019-06
• Study Completion: 2019-06
• Status Verified: 2019-10
• Last Update Submitted: 2019-10-30
• Last Update Posted: 2019-11-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• age 18 years or older
• current diagnosis of alcohol use disorder and self report of recent alcohol use
• pass an informed consent quiz
• agree to wear a SCRAMx monitor for 12 weeks
• have a standard SCRAMx compatible phone line in their home or agree to attend the clinic weekly for brief research visits/downloads
• agree to sign an off-campus property transfer form and return SCRAMx equipment

Exclusion Criteria

• serious, uncontrolled psychiatric illness
• in recovery from pathological gambling
• have an unstable address
• intend to participate in activities incompatible with SCRAMx over the next 3 months
• are wearing SCRAMx for legal purposes

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Experimental Group	Standard Care	Standard Care plus Prize Contingency Management for Alcohol Abstinence
Control Group	Standard Care	Standard Care
Experimental Group	Prize Contingency Management for Alcohol Abstinence	Standard Care plus Prize Contingency Management for Alcohol Abstinence

Primary Outcome Measures

Name	Time	Method
longest duration of abstinence from alcohol	three months	objective report of alcohol use as measured by SCRAMx device

Trial Locations

Locations (3)

The Hospital of Central Connecticut at New Britain General; 🇺🇸 New Britain, Connecticut, United States

Farrell Treatment Center; 🇺🇸 New Britain, Connecticut, United States

Behavioral Health Network, Inc.; 🇺🇸 Springfield, Massachusetts, United States